These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 11034582

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease.
    Kahrilas PJ, Quigley EM, Castell DO, Spechler SJ.
    Aliment Pharmacol Ther; 2000 Nov; 14(11):1503-9. PubMed ID: 11069322
    [Abstract] [Full Text] [Related]

  • 23. Gastric emptying and dyspeptic symptoms in patients with gastroesophageal reflux.
    Benini L, Sembenini C, Castellani G, Caliari S, Fioretta A, Vantini I.
    Am J Gastroenterol; 1996 Jul; 91(7):1351-4. PubMed ID: 8677993
    [Abstract] [Full Text] [Related]

  • 24. Pathophysiology of gastro-oesophageal reflux disease.
    De Giorgi F, Palmiero M, Esposito I, Mosca F, Cuomo R.
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):241-6. PubMed ID: 17345925
    [Abstract] [Full Text] [Related]

  • 25. Postprandial acid reflux is reduced by delayed gastric emptying.
    Yamashita Y, Mason RJ, Demeester TR.
    J Smooth Muscle Res; 2003 Aug; 39(4):87-93. PubMed ID: 14692694
    [Abstract] [Full Text] [Related]

  • 26. Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease.
    Netzer P, Schmitt B, Inauen W.
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1481-90. PubMed ID: 12182748
    [Abstract] [Full Text] [Related]

  • 27. [Ethiopathogenesis of gastroesophageal reflux disease].
    Lukás K, Marecek P.
    Cas Lek Cesk; 2000 Aug 02; 139(15):455-9. PubMed ID: 22666924
    [Abstract] [Full Text] [Related]

  • 28. Gastroesophageal reflux and gastric emptying, revisited.
    Emerenziani S, Sifrim D.
    Curr Gastroenterol Rep; 2005 Jun 02; 7(3):190-5. PubMed ID: 15913477
    [Abstract] [Full Text] [Related]

  • 29. The effect of cholecystokinin antagonism on postprandial lower oesophageal sphincter function in asymptomatic volunteers and patients with reflux disease.
    Trudgill NJ, Hussain FN, Moustafa M, Ajjan R, D'Amato M, Riley SA.
    Aliment Pharmacol Ther; 2001 Sep 02; 15(9):1357-64. PubMed ID: 11552906
    [Abstract] [Full Text] [Related]

  • 30. The influence of rapid food intake on postprandial reflux: studies in healthy volunteers.
    Wildi SM, Tutuian R, Castell DO.
    Am J Gastroenterol; 2004 Sep 02; 99(9):1645-51. PubMed ID: 15330896
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cisapride inhibits meal-stimulated gastric acid secretion and post-prandial gastric acidity in subjects with gastro-oesophageal reflux disease.
    Gardner JD, Rodriguez-Stanley S, Robinson M, Miner PB.
    Aliment Pharmacol Ther; 2002 Oct 02; 16(10):1819-29. PubMed ID: 12269977
    [Abstract] [Full Text] [Related]

  • 33. Effect of atropine on gastro-oesophageal reflux and transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease.
    Lidums I, Checklin H, Mittal RK, Holloway RH.
    Gut; 1998 Jul 02; 43(1):12-6. PubMed ID: 9771399
    [Abstract] [Full Text] [Related]

  • 34. Multivariate analysis of pathophysiological factors in reflux oesophagitis.
    Cadiot G, Bruhat A, Rigaud D, Coste T, Vuagnat A, Benyedder Y, Vallot T, Le Guludec D, Mignon M.
    Gut; 1997 Feb 02; 40(2):167-74. PubMed ID: 9071926
    [Abstract] [Full Text] [Related]

  • 35. The effects of bolus and continuous nasogastric feeding on gastro-oesophageal reflux and gastric emptying in healthy volunteers: a randomised three-way crossover pilot study.
    Bowling TE, Cliff B, Wright JW, Blackshaw PE, Perkins AC, Lobo DN.
    Clin Nutr; 2008 Aug 02; 27(4):608-13. PubMed ID: 18513835
    [Abstract] [Full Text] [Related]

  • 36. Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease.
    Maddern GJ, Jamieson GG, Myers JC, Collins PJ.
    Gut; 1991 May 02; 32(5):470-4. PubMed ID: 2040466
    [Abstract] [Full Text] [Related]

  • 37. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
    López-Alonso M, Moya MJ, Cabo JA, Ribas J, del Carmen Macías M, Silny J, Sifrim D.
    Pediatrics; 2006 Aug 02; 118(2):e299-308. PubMed ID: 16831894
    [Abstract] [Full Text] [Related]

  • 38. Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects.
    Kessing BF, Smout AJ, Bennink RJ, Kraaijpoel N, Oors JM, Bredenoord AJ.
    Neurogastroenterol Motil; 2014 Aug 02; 26(8):1079-86. PubMed ID: 24891067
    [Abstract] [Full Text] [Related]

  • 39. Solid and liquid gastric emptying in patients with gastro-oesophageal reflux.
    Maddern GJ, Chatterton BE, Collins PJ, Horowitz M, Shearman DJ, Jamieson GG.
    Br J Surg; 1985 May 02; 72(5):344-7. PubMed ID: 3995239
    [Abstract] [Full Text] [Related]

  • 40. Prolonged measurement of lower oesophageal sphincter function in patients with intestinal metaplasia at the oesophagogastric junction.
    Wolf C, Timmer R, Breumelhof R, Seldenrijk CA, Smout AJ.
    Gut; 2001 Sep 02; 49(3):354-8. PubMed ID: 11511556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.